PLATINIUM™ 4LV SonR* ¾ßÓÐ×óÐÄÊÒIS-4Ë﫯ð²«Ñ¡ÔñºÍSonR¹¦Ð§£¬£¬£¬£¬£¬£¬SonRÊÇÈ«ÇòµÚÒ»¸öÓµÓÐÓ¦ÓøÐÖªÆ÷ÓÅ»¯ÐÄÔàÔÙͬ²½ÖÎÁƵĹ¦Ð§µÄ²úÆ·¡£¡£¡£¡£¡£¡£
·¨¹ú£¬£¬£¬£¬£¬£¬¿ËÀÂí¶û——2018Äê6ÔÂ1ÈÕ£¬£¬£¬£¬£¬£¬Î¢´´®Ò½ÁÆ¿ÆÑ§ÓÐÏÞ¹«Ë¾£¨ÒÔϼò³Æ“΢´´®Ò½ÁÆ”£©ÆìϵÄ΢´´®ÐÄÂÉÖÎÀíÐû²¼£¬£¬£¬£¬£¬£¬ÆäPLATINIUM™ 4LV SonR CRT-DÐÄÔàÔÙͬ²½ÖÎÁÆ×°ÖúÍÅäÌ׵ľßÓÐÁ¢ÒìÊÖÒÕµÄSonRtip™µç¼«µ¼Ïß»ñµÃÁËÈÕ±¾Ò©Æ·ºÍÒ½ÁÆÆ÷еÖÎÀí¾ÖµÄÅú×¼¡£¡£¡£¡£¡£¡£
SonRϵͳӦÓÃǶÈëÔÚSonRtip™µç¼«µ¼ÏßÖÐÁ¢ÒìµÄ¸ÐÖªÐÄÔàËõ¶ÌÁ¦µÄ΢´«¸ÐÆ÷£¬£¬£¬£¬£¬£¬À´ÆÀ¹ÀÐÄÁ¦Ë¥½ß»¼Õß×óÐÄÊÒµÄËõ¶ÌÁ¦£¬£¬£¬£¬£¬£¬²¢ÓÅ»¯ÐÄÔàÔÙͬ²½ÖÎÁÆ£¨CRT£©¡£¡£¡£¡£¡£¡£Æ¾Ö¤»¼ÕßµÄÐÄÔàÔ˶¯ºÍÐèÒª£¬£¬£¬£¬£¬£¬¸ÃËã·¨×Ô¶¯ÓÅ»¯·¿ÊÒ¼äÆÚ£¨AV£©ºÍ×óÓÒÐÄÊÒ¼äÆÚ£¨VV£©µÄÉèÖ×—ÒÔµÖ´ï¸ÄÉÆÐÄÔ๦ЧµÄÄ¿µÄ¡£¡£¡£¡£¡£¡£Ã¿ÖÜͨ¹ý¶ÔÐÝÏ¢ºÍÔ˶¯Ê±¾ÙÐÐÓÅ»¯£¬£¬£¬£¬£¬£¬Ê¹ÖÎÁÆÄÜÒ»Á¬ÇкϸöÌåÐèÒª1¡£¡£¡£¡£¡£¡£
΢´´®Ò½ÁÆSonRרÀûÐÄÔàÔÙͬ²½ÖÎÁÆÏµÍ³µÄÇå¾²ÐÔºÍÁÙ´²ÓÐÓÃÐÔÒѾÔÚRESPOND- CRTÑо¿ÖлñµÃÁËÑéÖ¤¡£¡£¡£¡£¡£¡£RESPOND-CRTÑо¿ÊÇÒ»ÏîǰհÐÔ¡¢¶àÖÐÐÄ¡¢Ëæ»ú¡¢Ë«±Û¡¢Ë«Ã¤Ñо¿£¬£¬£¬£¬£¬£¬ÈëÑ¡ÁË1,000ÓàÃû»¼ÓÐÍíÆÚÐÄÁ¦Ë¥½ßµÄ»¼Õß¡£¡£¡£¡£¡£¡£ÕâÏîÑо¿½«SonRµÄ×Ô¶¯ÓÅ»¯ÓëÊÖ¶¯³¬ÉùÖ¸µ¼µÄÊÖ¹¤ÓÅ»¯¾ÙÐÐÁ˽ÏÁ¿¡£¡£¡£¡£¡£¡£
Ò»ÄêµÄÁÙ´²Êý¾ÝÏÔʾ£¬£¬£¬£¬£¬£¬¸ÃÑо¿Öª×ãÁËÇå¾²ÐÔºÍÓÐÓÃÐÔµÄÒ»¼¶Öյ㣬£¬£¬£¬£¬£¬ÇÒÊý¾ÝÅú×¢SonRµÄ×Ô¶¯ÓÅ»¯Ê¹ÐÄ˥סԺµÄΣº¦½µµÍÁË35%2¡£¡£¡£¡£¡£¡£
18¸öÔ»¼ÕßËæ·ÃµÄºã¾ÃЧ¹ûÈ·ÈÏÁËÐÄ˥סԺΣº¦µÄÏÔ׎µµÍ£¬£¬£¬£¬£¬£¬±ðµÄ£¬£¬£¬£¬£¬£¬Ñо¿ÏÔʾSonRÌØÊâÓÐÒæÓÚCRT·´Ó¦²îµÄÑÇ×黼Õß¡£¡£¡£¡£¡£¡£Ôںϲ¢Éö¹¦Ð§²»È«ºÍÓз¿²ü²¡Ê·µÄ»¼ÕßÖУ¬£¬£¬£¬£¬£¬SonRʹȫÒòéæÃüΣº¦½µµÍ45%£¬£¬£¬£¬£¬£¬ÐÄѪ¹ÜסԺΣº¦½µµÍ52%£»£»£»£»£»£»ÔÚ×óÊøÖ§×èÖͺÍÕQRS»¼ÕßÖУ¬£¬£¬£¬£¬£¬SonRʹȫÒòéæÃü»òHFסԺµÄΣº¦½µµÍ38%3¡£¡£¡£¡£¡£¡£
“SonRÓÅ»¯ÏµÍ³ÔÚRESPOND CRTÑо¿ÖÐÕ¹ÏÖÁËÓÅÒìµÄÁÙ´²Ð§¹û£¬£¬£¬£¬£¬£¬”΢´´®ÐÄÂÉÖÎÀí×ܲÃBenoît ClinchampsÌåÏÖ¡£¡£¡£¡£¡£¡£“³Ð¼Ì΢´´®Ò½ÁÆÎªÖйúÒÔÖÂÈ«Çò»¼ÕßÌṩÄÜÕü¾È²¢ÖØËÜ»¼ÕßÉúÃü»ò¸ÄÉÆÆäÉúÑÄÖÊÁ¿µÄ¸ßÐÔ¼Û±ÈÒ½ÁƼƻ®µÄʹÃü£¬£¬£¬£¬£¬£¬ÎÒÃǺÜÐË·Ü¿´µ½ÕâÏî¶ÀÍ̵ÄÁ¢ÒìÊÖÒÕÔÚÈÕ±¾»ñÅú£¬£¬£¬£¬£¬£¬Ô츣¸ü¶àÈÕ±¾ÍíÆÚÐÄÁ¦Ë¥½ß»¼Õß¡£¡£¡£¡£¡£¡£”
¹ØÓÚCRT
ÐÄÔàÔÙͬ²½ÖÎÁÆ(CRT)ÊǶÔÐÄÔà¸÷ÐÄÇ»ÌṩʵʱµÄµçÂö³åµÄÒ»ÖÖÖÎÁÆ¡£¡£¡£¡£¡£¡£ÕâÖÖÈÃÐÄÌøÔ½·¢Ðе÷ͬ²½µÄ·½·¨£¬£¬£¬£¬£¬£¬¿ÉÒÔ¸ÄÉÆÐÄÔà±ÃѪЧÂʺÍѪҺÁ÷¶¯¡£¡£¡£¡£¡£¡£È»¶ø£¬£¬£¬£¬£¬£¬Ñо¿ÏÔʾԼĪÓÐÈý·ÖÖ®Ò»µÄÍíÆÚÐÄÁ¦Ë¥½ß»¼Õß¶ÔCRTÎÞÓÐÓ÷´Ó¦¡£¡£¡£¡£¡£¡£CRT·´Ó¦²»¼ÑµÄÒ»¸öÖ÷ÒªÔµ¹ÊÔÓÉÊDz»¶ÔÊʵÄAVºÍVV¼äÆÚ¡£¡£¡£¡£¡£¡£
¹ØÓÚRESPOND-CRTÑо¿
RESPOND-CRTÑо¿ÊÇÒ»ÏîǰհÐÔ¡¢¶àÖÐÐÄ¡¢Ëæ»ú¡¢Ë«Ã¤Ñо¿£¬£¬£¬£¬£¬£¬Ö¼ÔÚÆÀ¹ÀSonRϵͳµÄÇå¾²ÐÔºÍÓÐÓÃÐÔ¡£¡£¡£¡£¡£¡£Ñо¿ÔÚÅ·ÖÞ¡¢ÃÀ¹úºÍ°Ä´óÀûÑǵÄ125ÆäÖÐÐÄÈëÑ¡ÁË1039ÃûÖ²ÈëCRT-D×°ÖõϼÕß¡£¡£¡£¡£¡£¡£»£»£»£»£»£»¼Õß±»Ëæ»ú2:1Ó¦ÓÃSonRϵͳ»ò³¬Éù¾ÙÐÐAV»òVVÓÅ»¯¡£¡£¡£¡£¡£¡£Ö÷ÒªÆÊÎöÔÚ12¸öÔÂʱ¾ÙÐУ¬£¬£¬£¬£¬£¬´Î¼¶ÆÊÎöÔÚ18¸öÔÂʱ¾ÙÐС£¡£¡£¡£¡£¡£
RESPOND-CRTÊÔÑéÊÇÒ»Ïîͨ¹ýÃÀ¹úʳÎïºÍÒ©ÎïÖÎÀí¾Ö(FDA)Åú×¼µÄÑо¿×°±¸×°ÖÿíÃâ(IDE)Ñо¿¡£¡£¡£¡£¡£¡£¸ÃÑо¿Öª×ãÁËËùÓÐÖ÷ÒªµÄÇå¾²ÐÔºÍÓÐÓÃÐÔÖյ㡣¡£¡£¡£¡£¡£SonRtip™µç¼«µ¼Ïß±»Ö¤ÊµÊÇÇå¾²µÄ£¬£¬£¬£¬£¬£¬Ö»ÓÐ1%µÄ»¼Õß±¨¸æµç¼«µ¼ÏßÍÑλºÍ0.1%µÄ»¼Õß±¨¸æµç¼«µ¼Ïß¶ÏÁÑ¡£¡£¡£¡£¡£¡£Æ¾Ö¤·´Ó¦ÂÊ£¬£¬£¬£¬£¬£¬Ö¤ÊµSonRµÄÓÅ»¯Ó볬ÉùÖ¸µ¼µÄÓÅ»¯Ò»ÑùÓÐÓᣡ£¡£¡£¡£¡£ÔÚ12¸öÔÂʱ£¬£¬£¬£¬£¬£¬Æ¾Ö¤ÒÔÏ·ֲãµÄ±ê×¼½ç˵»¼ÕßÓз´Ó¦£º»¼Õß´æ»î£¬£¬£¬£¬£¬£¬ÎÞÐÄÁ¦Ë¥½ßÊÂÎñ£¬£¬£¬£¬£¬£¬¸ÄÉÆNYHA¹¦Ð§·Ö¼¶»òÉúÑÄÖÊÁ¿¡£¡£¡£¡£¡£¡£·´Ó¦ÂÊÔÚSonR×éºÍ³¬Éù×é»®·ÖΪ75%ºÍ70.4%[P < 0.0001 ·ÇÁÓЧ]¡£¡£¡£¡£¡£¡£¸ÃÑо¿µÄÉè¼ÆÒѾÓÚ2014Äê½ÒÏþÔÚÃÀ¹úÐÄÔàÔÓÖ¾ÉÏ¡£¡£¡£¡£¡£¡£
¹ØÓÚSonRËõ¶ÌÁ¦´«¸ÐÆ÷
SonRÓÅ»¯ÏµÍ³°üÀ¨ÓÐǶÈëSonR΢ÐͼÓËÙÂÊ´«¸ÐÆ÷µÄSonRtip™ÐÄ·¿Æð²«µç¼«µ¼ÏߺÍÓÐSonRÓÅ»¯Ëã·¨µÄPLATINIUM™SonR CRT-D×°Öᣡ£¡£¡£¡£¡£
10ÄêÁÙ´²¿ÆÑÐÏîÄ¿µÄЧ¹ûÏÔʾ£¬£¬£¬£¬£¬£¬SonR´«¸ÐÆ÷¿ÉÒÔÆæÒìµØÕÉÁ¿»¼ÕßÔÚÐÄÔàÐļ¡Ëõ¶Ìʱ±¬·¢µÄÐļ¡Õñ¶¯¡£¡£¡£¡£¡£¡£×óÐÄÊÒËõ¶ÌÁ¦ÊÇ·´Ó¦ÐÄÔàÐÔÄܵÄÒªº¦Ö¸±ê£¬£¬£¬£¬£¬£¬SonRÕÉÁ¿µÄLV dP/dt maxÔòÊÇȨºâ×óÐÄÊÒËõ¶ÌÁ¦µÄ½ð±ê×¼¡£¡£¡£¡£¡£¡£ÕâЩʵʱÕÉÁ¿´«Êäµ½CRT-D×°Ö㬣¬£¬£¬£¬£¬×°ÖÃÓ¦ÓÃÕâЩÊý¾ÝÀ´È·¶¨»¼ÕßµÄ×î¼ÑÉèÖᣡ£¡£¡£¡£¡£Ã¿¸öÐÇÆÚ£¬£¬£¬£¬£¬£¬ÏµÍ³×Ô¶¯ÓÅ»¯ÒÔ˳Ӧ»¼ÕßµÄÉíÌå״̬¸Ä±ä¡£¡£¡£¡£¡£¡£SonR ÊÇΨһ»ùÓÚËõ¶ÌÁ¦´«¸ÐÆ÷µÄCRTÓÅ»¯ÏµÍ³£¬£¬£¬£¬£¬£¬Ã¿ÖÜ×Ô¶¯ÓÅ»¯£¬£¬£¬£¬£¬£¬Ö÷ÒªµÄÊÇ£¬£¬£¬£¬£¬£¬µ±»¼Õß´¦ÓÚÔ˶¯×´Ì¬Ê±Äܹ»ÌṩʵʱµÄÓÅ»¯¡£¡£¡£¡£¡£¡£
SonRÊÇ΢´´®ÐÄÂÉÖÎÀíCRT²úÆ·ÖÐÒ»Ïî¶ÀÍ̵ÄÊÖÒÕ¡£¡£¡£¡£¡£¡£
References
1. Brugada J., Brachmann J., Delnoy P.P., et al. Automatic optimization of cardiac resynchronization therapy using SonR-rationale and design of the clinical trial of the SonRtip lead and automatic AV-VV optimization algorithm in the paradym RF SonR CRT-D (RESPOND-CRT) trial. Am Heart J 2014;167:429-36.
2. Brugada J., Delnoy P.P., Brachmann J. et al. Contractility sensor-guided optimization of cardiac resynchronization therapy: results from the RESPOND-CRT trial. Eur Heart J. 2017 Mar 7; 38(10): 730-738.
3. Singh J., Aydin A., Murgatroyd F. et al. Automatic contractility sonsor-guided optimization is associated with improved outcomes in CRT subgroups at high risk of non-response. Heart Rhythm 2017; 14(Suppl 5.): C-AB36-02